US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.6430
  • +0.0143+2.27%
Close Nov 29 13:00 ET
  • 0.6430
  • 0.00000.00%
Post 17:01 ET
3.27MMarket Cap-135P/E (TTM)

Matinas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
20.80%-3.5M
-41.63%-3.11M
-41.15%-5.77M
20.24%-15.28M
-6.51%-4.58M
11.09%-4.42M
57.26%-2.19M
14.07%-4.09M
-25.84%-19.16M
-8.64%-4.3M
Net income from continuing operations
29.40%-4.28M
5.63%-5.72M
-5.64%-5.82M
-9.26%-22.94M
-46.23%-5.31M
-10.86%-6.06M
-2.31%-6.06M
7.78%-5.51M
9.82%-21M
45.75%-3.63M
Operating gains losses
----
----
----
-50.00%1K
----
----
----
----
0.00%2K
----
Depreciation and amortization
2.52%244K
2.99%241K
4.80%240K
4.79%941K
6.19%240K
3.48%238K
1.30%234K
8.53%229K
14.98%898K
10.45%226K
Other non cash items
-82.35%3K
-227.59%-37K
-59.09%18K
-78.69%107K
-67.92%17K
-64.58%17K
-40.82%29K
-87.50%44K
-65.38%502K
-31.85%53K
Change In working capital
-336.22%-437K
-40.82%1.42M
-906.72%-1.2M
134.81%1.67M
65.22%-795K
115.43%185K
440.83%2.4M
80.20%-119K
-411.99%-4.79M
-265.31%-2.29M
-Change in prepaid assets
108.74%25K
-35.18%1.21M
-116.24%-393K
194.90%3.98M
99.15%-13K
54.31%-286K
185.73%1.86M
1,883.61%2.42M
-410.89%-4.2M
-219.51%-1.52M
-Change in payables and accrued expense
-147.56%-293K
-44.76%369K
72.95%-651K
-2,336.11%-1.75M
0.79%-631K
240.64%616K
-58.20%668K
-303.86%-2.41M
-111.16%-72K
-371.37%-636K
-Change in other current liabilities
-16.55%-169K
-17.91%-158K
-16.67%-154K
-8.08%-562K
-17.05%-151K
-7.41%-145K
-3.88%-134K
-3.94%-132K
-13.04%-520K
-3.89%-129K
Cash from discontinued investing activities
Operating cash flow
20.80%-3.5M
-41.63%-3.11M
-41.15%-5.77M
20.24%-15.28M
-6.51%-4.58M
11.09%-4.42M
57.26%-2.19M
14.07%-4.09M
-25.84%-19.16M
-8.64%-4.3M
Investing cash flow
Cash flow from continuing investing activities
789.85%9.65M
-147.40%-2.94M
-33.33%2M
171.52%13.24M
7,147.62%2.96M
-81.15%1.08M
263.45%6.2M
1.32%3M
-70.92%4.88M
-174.14%-42K
Net PPE purchase and sale
--0
----
----
75.56%-218K
--0
93.60%-16K
----
----
-243.08%-892K
-17.28%-42K
Net investment purchase and sale
776.91%9.65M
-145.91%-2.94M
-33.33%2M
133.32%13.46M
--2.96M
-81.67%1.1M
271.26%6.4M
-14.43%3M
-66.12%5.77M
--0
Cash from discontinued investing activities
Investing cash flow
789.85%9.65M
-147.40%-2.94M
-33.33%2M
171.52%13.24M
7,147.62%2.96M
-81.15%1.08M
263.45%6.2M
1.32%3M
-70.92%4.88M
-174.14%-42K
Financing cash flow
Cash flow from continuing financing activities
-6,600.00%-67K
919,000.00%9.19M
1,425.00%53K
-108.86%-7K
80.00%-1K
66.67%-1K
83.33%-1K
-104.30%-4K
-98.87%79K
-160.02%-5K
Net issuance payments of debt
-100.00%-2K
0.00%-1K
75.00%-1K
65.00%-7K
80.00%-1K
66.67%-1K
83.33%-1K
33.33%-4K
33.33%-20K
9.76%-5K
Net common stock issuance
---65K
--9.19M
--54K
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
-93.00%99K
--0
Cash from discontinued financing activities
Financing cash flow
-6,600.00%-67K
919,000.00%9.19M
1,425.00%53K
-108.86%-7K
80.00%-1K
66.67%-1K
83.33%-1K
-104.30%-4K
-98.87%79K
-160.02%-5K
Net cash flow
Beginning cash position
-55.31%4.47M
-77.94%1.32M
-28.86%5.04M
-66.73%7.08M
-41.74%6.66M
-6.16%9.99M
-69.41%5.99M
-66.73%7.08M
66.67%21.28M
-54.61%11.43M
Current changes in cash
282.22%6.08M
-21.45%3.15M
-240.60%-3.72M
85.61%-2.04M
62.72%-1.62M
-529.34%-3.34M
144.84%4M
35.90%-1.09M
-266.82%-14.2M
-11.66%-4.35M
End cash Position
58.40%10.55M
-55.31%4.47M
-77.94%1.32M
-28.86%5.04M
-28.86%5.04M
-41.74%6.66M
-6.16%9.99M
-69.41%5.99M
-66.73%7.08M
-66.73%7.08M
Free cash flow
21.08%-3.5M
-29.69%-3.11M
-41.15%-5.77M
22.71%-15.5M
-5.48%-4.58M
15.04%-4.44M
53.82%-2.4M
22.90%-4.09M
-29.48%-20.05M
-8.71%-4.34M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 20.80%-3.5M-41.63%-3.11M-41.15%-5.77M20.24%-15.28M-6.51%-4.58M11.09%-4.42M57.26%-2.19M14.07%-4.09M-25.84%-19.16M-8.64%-4.3M
Net income from continuing operations 29.40%-4.28M5.63%-5.72M-5.64%-5.82M-9.26%-22.94M-46.23%-5.31M-10.86%-6.06M-2.31%-6.06M7.78%-5.51M9.82%-21M45.75%-3.63M
Operating gains losses -------------50.00%1K----------------0.00%2K----
Depreciation and amortization 2.52%244K2.99%241K4.80%240K4.79%941K6.19%240K3.48%238K1.30%234K8.53%229K14.98%898K10.45%226K
Other non cash items -82.35%3K-227.59%-37K-59.09%18K-78.69%107K-67.92%17K-64.58%17K-40.82%29K-87.50%44K-65.38%502K-31.85%53K
Change In working capital -336.22%-437K-40.82%1.42M-906.72%-1.2M134.81%1.67M65.22%-795K115.43%185K440.83%2.4M80.20%-119K-411.99%-4.79M-265.31%-2.29M
-Change in prepaid assets 108.74%25K-35.18%1.21M-116.24%-393K194.90%3.98M99.15%-13K54.31%-286K185.73%1.86M1,883.61%2.42M-410.89%-4.2M-219.51%-1.52M
-Change in payables and accrued expense -147.56%-293K-44.76%369K72.95%-651K-2,336.11%-1.75M0.79%-631K240.64%616K-58.20%668K-303.86%-2.41M-111.16%-72K-371.37%-636K
-Change in other current liabilities -16.55%-169K-17.91%-158K-16.67%-154K-8.08%-562K-17.05%-151K-7.41%-145K-3.88%-134K-3.94%-132K-13.04%-520K-3.89%-129K
Cash from discontinued investing activities
Operating cash flow 20.80%-3.5M-41.63%-3.11M-41.15%-5.77M20.24%-15.28M-6.51%-4.58M11.09%-4.42M57.26%-2.19M14.07%-4.09M-25.84%-19.16M-8.64%-4.3M
Investing cash flow
Cash flow from continuing investing activities 789.85%9.65M-147.40%-2.94M-33.33%2M171.52%13.24M7,147.62%2.96M-81.15%1.08M263.45%6.2M1.32%3M-70.92%4.88M-174.14%-42K
Net PPE purchase and sale --0--------75.56%-218K--093.60%-16K---------243.08%-892K-17.28%-42K
Net investment purchase and sale 776.91%9.65M-145.91%-2.94M-33.33%2M133.32%13.46M--2.96M-81.67%1.1M271.26%6.4M-14.43%3M-66.12%5.77M--0
Cash from discontinued investing activities
Investing cash flow 789.85%9.65M-147.40%-2.94M-33.33%2M171.52%13.24M7,147.62%2.96M-81.15%1.08M263.45%6.2M1.32%3M-70.92%4.88M-174.14%-42K
Financing cash flow
Cash flow from continuing financing activities -6,600.00%-67K919,000.00%9.19M1,425.00%53K-108.86%-7K80.00%-1K66.67%-1K83.33%-1K-104.30%-4K-98.87%79K-160.02%-5K
Net issuance payments of debt -100.00%-2K0.00%-1K75.00%-1K65.00%-7K80.00%-1K66.67%-1K83.33%-1K33.33%-4K33.33%-20K9.76%-5K
Net common stock issuance ---65K--9.19M--54K----------0--0--0--------
Proceeds from stock option exercised by employees --------------0-----------------93.00%99K--0
Cash from discontinued financing activities
Financing cash flow -6,600.00%-67K919,000.00%9.19M1,425.00%53K-108.86%-7K80.00%-1K66.67%-1K83.33%-1K-104.30%-4K-98.87%79K-160.02%-5K
Net cash flow
Beginning cash position -55.31%4.47M-77.94%1.32M-28.86%5.04M-66.73%7.08M-41.74%6.66M-6.16%9.99M-69.41%5.99M-66.73%7.08M66.67%21.28M-54.61%11.43M
Current changes in cash 282.22%6.08M-21.45%3.15M-240.60%-3.72M85.61%-2.04M62.72%-1.62M-529.34%-3.34M144.84%4M35.90%-1.09M-266.82%-14.2M-11.66%-4.35M
End cash Position 58.40%10.55M-55.31%4.47M-77.94%1.32M-28.86%5.04M-28.86%5.04M-41.74%6.66M-6.16%9.99M-69.41%5.99M-66.73%7.08M-66.73%7.08M
Free cash flow 21.08%-3.5M-29.69%-3.11M-41.15%-5.77M22.71%-15.5M-5.48%-4.58M15.04%-4.44M53.82%-2.4M22.90%-4.09M-29.48%-20.05M-8.71%-4.34M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data